"In our study of the liver and its blood vessels, we identified an important trigger for organ growth. For the first time, we were able to show that blood flow and vasodilatation release growth-promoting signals from blood vessels," said Professor Eckhard Lammert, director of the Institute for Beta Cell Biology at the German Diabetes Center (DDZ) and head of the Institute for Metabolic Physiology at Heinrich Heine University Düsseldorf. "In the future, these exciting results could also become important for the understanding and treatment of fatty liver disease in obesity and diabetes," added Professor Michael Roden, scientific director and board member of the German Diabetes Center and director of the Department of Endocrinology and Diabetology at Düsseldorf University Hospital." The research results are of great importance for understanding the complex processes involved in liver regeneration and its disorders," said Professor Dieter Häussinger, director of the Department of Gastroenterology, Hepatology and Infectious Diseases at Düsseldorf University Hospital and spokesperson of the Collaborative Research Center 974.
The molecular causes of this organ regeneration are the subject of a study published by Düsseldorf scientists in the journal Nature (Lorenz et al., Nature 2018). Specifically, the scientists were able to show that increased blood flow through the liver leads to the release and activation of growth signals from blood vessels. One of these signals is the hepatocyte growth factor (HGF), which is particularly important for the growth and survival of liver cells. The endothelial cells of the blood vessels recognize the increased blood flow through the liver by means of so-called integrins. These are cell surface proteins that connect the extracellular matrix to the cytoskeleton and are able to activate other receptors such as the vascular endothelial growth factor receptor-3 (VEGFR3). The activation of the β1 integrin (a subunit of the integrins) due to the increased blood flow leads in endothelial cells to the activation of VEGFR3 and the activation and release of growth factors such as HGF. The latter induce the growth of the liver. As soon as the liver has grown to its normal size and new blood vessels have formed, a normal amount of blood per endothelial cell flows through the liver again. This normal mechanical stimulation of the endothelial cells could explain why the liver stops growing. The scientists postulate that this molecular mechanism causes the liver to grow as soon as its organ size is reduced and then to stop growing when it is restored.
Photo Reference: A video about the study can be found at https://figshare.com/s/f7ceb9d5980d10084ad8
Original Publication:Lorenz L, Axnick J, Buschmann T, Henning C, Urner S, Fang S, Nurmi H, Eichhorst N, Holtmeier R, Bódis K, Hwang JH, Müssig K, Eberhard D, Stypmann J, Kuss O, Roden M, Alitalo K, Häussinger D, Lammert E. Mechanosensing by β1 integrin induces angiocrine signals for liver growth and survival. Nature. 2018 Sep 26. doi: 10.1038/s41586-018-0522-3. [Epub ahead of print]
Christina A. Becker (M.A.)
Deutsches Diabetes-Zentrum (DDZ)
Leibniz-Zentrum für Diabetes-Forschung
an der Heinrich-Heine-Universität Düsseldorf
Auf´m Hennekamp 65
D - 40225 Düsseldorf